The Genetics and Personalized Cancer Prevention Program at Weill Cornell Medicine is excited to announce our upcoming Innovations in Cancer Genetics Symposium, taking place October 15–17, 2026, in New York City at Weill Cornell Medicine. 

This cutting-edge symposium, hosted by the Genetics and Personalized Cancer Prevention Program at Weill Cornell Medicine in partnership with Facing Our Risk for Cancer Empowered (FORCE), will highlight the latest advances in cancer genetics and their impact on clinical care and personalized prevention. The program will bring together nationally recognized experts in hereditary cancer to: 

• Share emerging research and practical clinical insights 

• Explore innovations in personalized cancer prevention 

• Foster collaboration across clinical care, research, and patient advocacy 

Physicians

Weill Cornell Medical College is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Weill Cornell Medical College designates this live activity for a maximum of 19.50 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.